The histone acetyltransferase MOZ (KAT6A) is a molecular dependency and therapeutic target in NUP98-rearranged acute myeloid leukemia Meeting Abstract


Authors: Michmerhuizen, N. L.; Heikamp, E.; Umeda, M.; Iacobucci, I.; Arthur, B.; Di Giacomo, D.; Hiltenbrand, R.; Radko-Juettner, S.; Portola, P.; Claquin, A.; Chandra, B.; Baggett, D. W.; Huang, H.; Zhou, P.; Long, L.; Shi, H.; Sun, Y.; Papachristou, E. K.; Chilamakuri, C. S. R.; de L. Vitorino, F. N.; Gongora, J. M.; D'Santos, C. S.; Garcia, B. A.; Kriwacki, R. W.; Chi, H.; Kentsis, A.; Armstrong, S. A.; Klco, J. M.; Mullighan, C. G.
Abstract Title: The histone acetyltransferase MOZ (KAT6A) is a molecular dependency and therapeutic target in NUP98-rearranged acute myeloid leukemia
Meeting Title: 66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 144
Issue: Suppl. 1
Meeting Dates: 2024 Dec 7-10
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2024-11-05
Start Page: 825
End Page: 826
Language: English
ACCESSION: WOS:001412608600018
DOI: 10.1182/blood-2024-210529
PROVIDER: wos
Notes: Meeting Abstract -- Hybrid event -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alex   Kentsis
    103 Kentsis